These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35660215)

  • 21. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Fertility and Forecasting Collaborators
    Lancet; 2024 May; 403(10440):2057-2099. PubMed ID: 38521087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple myeloma incidence, mortality, and prevalence estimates and projections, Australia, 1982-2043: a statistical modelling study.
    Luo Q; Jenkin D; Weber MF; Steinberg J; White K; Irving A; Rillstone H; Kelly A; Canfell K; Feletto E
    Med J Aust; 2024 Jul; 221(2):103-110. PubMed ID: 39003689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Projections of smoking-related cancer mortality in Australia to 2044.
    Luo Q; Steinberg J; Yu XQ; Weber M; Caruana M; Yap S; Grogan PB; Banks E; O'Connell DL; Canfell K
    J Epidemiol Community Health; 2022 Jun; 76(9):792-9. PubMed ID: 35750482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer mortality in Australia: Projected outcomes to 2040.
    Luo Q; Yu XQ; Wade S; Caruana M; Pesola F; Canfell K; O'Connell DL
    Lung Cancer; 2018 Nov; 125():68-76. PubMed ID: 30429040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premature mortality projections in the USA through 2030: a modelling study.
    Best AF; Haozous EA; Berrington de Gonzalez A; Chernyavskiy P; Freedman ND; Hartge P; Thomas D; Rosenberg PS; Shiels MS
    Lancet Public Health; 2018 Aug; 3(8):e374-e384. PubMed ID: 30037721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
    Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicted long-term impact of COVID-19 pandemic-related care delays on cancer mortality in Canada.
    Malagón T; Yong JHE; Tope P; Miller WH; Franco EL;
    Int J Cancer; 2022 Apr; 150(8):1244-1254. PubMed ID: 34843106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study.
    Krishnamurthi RV; Moran AE; Feigin VL; Barker-Collo S; Norrving B; Mensah GA; Taylor S; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
    Neuroepidemiology; 2015; 45(3):190-202. PubMed ID: 26505983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    GBD 2013 Mortality and Causes of Death Collaborators
    Lancet; 2015 Jan; 385(9963):117-71. PubMed ID: 25530442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Dementia Collaborators
    Lancet Neurol; 2019 Jan; 18(1):88-106. PubMed ID: 30497964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Foreman KJ; Marquez N; Dolgert A; Fukutaki K; Fullman N; McGaughey M; Pletcher MA; Smith AE; Tang K; Yuan CW; Brown JC; Friedman J; He J; Heuton KR; Holmberg M; Patel DJ; Reidy P; Carter A; Cercy K; Chapin A; Douwes-Schultz D; Frank T; Goettsch F; Liu PY; Nandakumar V; Reitsma MB; Reuter V; Sadat N; Sorensen RJD; Srinivasan V; Updike RL; York H; Lopez AD; Lozano R; Lim SS; Mokdad AH; Vollset SE; Murray CJL
    Lancet; 2018 Nov; 392(10159):2052-2090. PubMed ID: 30340847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
    Degeling K; Baxter NN; Emery J; Jenkins MA; Franchini F; Gibbs P; Mann GB; McArthur G; Solomon BJ; IJzerman MJ
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):359-367. PubMed ID: 33567163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Tuberculosis Collaborators
    Lancet Infect Dis; 2024 Jul; 24(7):698-725. PubMed ID: 38518787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
    Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
    Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annual report to the nation on the status of cancer, part I: National cancer statistics.
    Henley SJ; Ward EM; Scott S; Ma J; Anderson RN; Firth AU; Thomas CC; Islami F; Weir HK; Lewis DR; Sherman RL; Wu M; Benard VB; Richardson LC; Jemal A; Cronin K; Kohler BA
    Cancer; 2020 May; 126(10):2225-2249. PubMed ID: 32162336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.
    Melaku YA; Appleton SL; Gill TK; Ogbo FA; Buckley E; Shi Z; Driscoll T; Adams R; Cowie BC; Fitzmaurice C
    Cancer Epidemiol; 2018 Feb; 52():43-54. PubMed ID: 29216565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.